InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Dayno Jeffrey M., Directeur Médical. Insider active across 1 companies, notably Harmony Biosciences Holdings, Inc.. Aggregated, 12 disclosures have been recorded. The latest transaction was disclosed on 19 October 2021 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Declarations12 total
€99,63414,099 shares@ €7.06670.0057% mcap37.3% of flow
Common Stock
SEC:0001104659-21-128203·
€99,63414,099 shares@ €7.06670.0057% mcap18.7% of flow
Common Stock
SEC:0001104659-21-128203:0·
€12,8041,800 shares@ €7.11360.0007% mcap4.8% of flow
Common Stock
SEC:0001104659-21-124273·
€12,8041,800 shares@ €7.11360.0007% mcap2.4% of flow
Common Stock
SEC:0001104659-21-124273:0·
€69,40510,000 shares@ €6.94050.0040% mcap26.0% of flow
Common Stock
SEC:0000899243-21-035505·
€69,40510,000 shares@ €6.94050.0040% mcap13.0% of flow
Common Stock
SEC:0000899243-21-035505:0·
€15,0962,159 shares@ €6.99190.0009% mcap5.7% of flow
Common Stock
SEC:0000899243-21-034517·
€15,0962,159 shares@ €6.99190.0009% mcap2.8% of flow
Common Stock
SEC:0000899243-21-034517:0·
€69,7669,950 shares@ €7.01170.0040% mcap26.1% of flow
Common Stock
SEC:0000899243-21-032526·
€69,7669,950 shares@ €7.01170.0040% mcap13.1% of flow
Common Stock
SEC:0000899243-21-032526:0·
€34950 shares@ €6.98220.0000% mcap0.1% of flow
Common Stock
SEC:0000899243-21-029687·
€34950 shares@ €6.98220.0000% mcap0.1% of flow
Common Stock
SEC:0000899243-21-029687:0·
12 of 12 declarations
About Dayno Jeffrey M.
Dayno Jeffrey M. is the Chief Medical Officer at Harmony Biosciences Holdings, Inc. In this role, he oversees the company's medical and clinical activities, ensuring innovation and regulatory compliance. His expertise in medicine and pharmaceutical product development is essential for achieving Harmony Biosciences's growth objectives.
